FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415708755> ?p ?o ?g. }

• W2415708755 endingPage "1193" @default.
• W2415708755 startingPage "1187" @default.
• W2415708755 abstract "Background The difference in clinical presentation, causality assessments, and outcomes of patients with delayed antibiotic-associated cutaneous adverse drug reactions (AA-cADR) and nonantibiotic-associated (NA)-cADR is ill defined. Objective We examined the etiology of AA-cADR, with regard to the type of antibiotic exposure, allergy labeling, and patient outcomes, in comparison with NA-cADR. Methods A retrospective observational inpatient cohort study of cADR was performed from January 2004 to August 2014. Patients were divided into AA-cADR and NA-cADR groups for analysis. cADR was defined as erythema multiforme, fixed drug eruption, acute generalized erythematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-associated linear IgA disease, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Results Of the 84 patients with cADR, 48% were AA-cADR. Male sex (60% vs 32%, P = .004), median length of stay (14.5 vs 11 days, P = .05), median Charlson comorbidity index (3 vs 1, P = .03), and inpatient mortality (20% vs 5%, P = .04) were higher in AA-cADR compared with NA-cADR. The median drug latency was lower in AA-cADR (6 vs 20 days, P = .001). Sulfonamide antibiotics and glycopeptides were implicated in 20% of AA-cADR. DRESS was more frequently reported in AA-cADR. After cADR diagnosis, further antibiotic therapy was administered in 64% of patients, higher in AA-cADR (75%, 30 of 40) compared with NA-cADR (55%, 24 of 44) (P = .06). Fluoroquinolones (53% vs 21%, P = .02), glycopeptides (vancomycin and teicoplanin; 70% vs 38%, P = .05), and carbapenems (33% vs 13%, P = .11) were used more commonly in AA-cADR. Conclusions Antibiotics were the cause of cADR requiring hospital admission in 48% of episodes, and were associated with longer length of stay, higher age-adjusted Charlson comorbidity index, shorter drug latency, and mortality. In AA-cADR, glycopeptide and sulfonamide antibiotic exposure predominated. The difference in clinical presentation, causality assessments, and outcomes of patients with delayed antibiotic-associated cutaneous adverse drug reactions (AA-cADR) and nonantibiotic-associated (NA)-cADR is ill defined. We examined the etiology of AA-cADR, with regard to the type of antibiotic exposure, allergy labeling, and patient outcomes, in comparison with NA-cADR. A retrospective observational inpatient cohort study of cADR was performed from January 2004 to August 2014. Patients were divided into AA-cADR and NA-cADR groups for analysis. cADR was defined as erythema multiforme, fixed drug eruption, acute generalized erythematous pustulosis, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-associated linear IgA disease, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Of the 84 patients with cADR, 48% were AA-cADR. Male sex (60% vs 32%, P = .004), median length of stay (14.5 vs 11 days, P = .05), median Charlson comorbidity index (3 vs 1, P = .03), and inpatient mortality (20% vs 5%, P = .04) were higher in AA-cADR compared with NA-cADR. The median drug latency was lower in AA-cADR (6 vs 20 days, P = .001). Sulfonamide antibiotics and glycopeptides were implicated in 20% of AA-cADR. DRESS was more frequently reported in AA-cADR. After cADR diagnosis, further antibiotic therapy was administered in 64% of patients, higher in AA-cADR (75%, 30 of 40) compared with NA-cADR (55%, 24 of 44) (P = .06). Fluoroquinolones (53% vs 21%, P = .02), glycopeptides (vancomycin and teicoplanin; 70% vs 38%, P = .05), and carbapenems (33% vs 13%, P = .11) were used more commonly in AA-cADR. Antibiotics were the cause of cADR requiring hospital admission in 48% of episodes, and were associated with longer length of stay, higher age-adjusted Charlson comorbidity index, shorter drug latency, and mortality. In AA-cADR, glycopeptide and sulfonamide antibiotic exposure predominated." @default.
• W2415708755 created "2016-06-24" @default.
• W2415708755 creator A5020382844 @default.
• W2415708755 creator A5021358102 @default.
• W2415708755 creator A5026695094 @default.
• W2415708755 creator A5038304654 @default.
• W2415708755 creator A5047746565 @default.
• W2415708755 creator A5082837962 @default.
• W2415708755 creator A5086939354 @default.
• W2415708755 creator A5087023094 @default.
• W2415708755 date "2016-11-01" @default.
• W2415708755 modified "2023-10-11" @default.
• W2415708755 title "A Comparative Analysis Between Antibiotic- and Nonantibiotic-Associated Delayed Cutaneous Adverse Drug Reactions" @default.
• W2415708755 cites W1546747274 @default.
• W2415708755 cites W1765914614 @default.
• W2415708755 cites W1901880560 @default.
• W2415708755 cites W1967300023 @default.
• W2415708755 cites W1978598106 @default.
• W2415708755 cites W2000445173 @default.
• W2415708755 cites W2005561958 @default.
• W2415708755 cites W2005673189 @default.
• W2415708755 cites W2009578062 @default.
• W2415708755 cites W2022518753 @default.
• W2415708755 cites W2025160125 @default.
• W2415708755 cites W2031301975 @default.
• W2415708755 cites W2051267089 @default.
• W2415708755 cites W2066724445 @default.
• W2415708755 cites W2067978628 @default.
• W2415708755 cites W2107154370 @default.
• W2415708755 cites W2108295299 @default.
• W2415708755 cites W2119260702 @default.
• W2415708755 cites W2134373673 @default.
• W2415708755 cites W2134537227 @default.
• W2415708755 cites W2153972688 @default.
• W2415708755 cites W2154589023 @default.
• W2415708755 cites W2156525348 @default.
• W2415708755 cites W2215759648 @default.
• W2415708755 doi "https://doi.org/10.1016/j.jaip.2016.04.026" @default.
• W2415708755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27283055" @default.
• W2415708755 hasPublicationYear "2016" @default.
• W2415708755 type Work @default.
• W2415708755 sameAs 2415708755 @default.
• W2415708755 citedByCount "35" @default.
• W2415708755 countsByYear W24157087552016 @default.
• W2415708755 countsByYear W24157087552017 @default.
• W2415708755 countsByYear W24157087552018 @default.
• W2415708755 countsByYear W24157087552019 @default.
• W2415708755 countsByYear W24157087552020 @default.
• W2415708755 countsByYear W24157087552021 @default.
• W2415708755 countsByYear W24157087552022 @default.
• W2415708755 countsByYear W24157087552023 @default.
• W2415708755 crossrefType "journal-article" @default.
• W2415708755 hasAuthorship W2415708755A5020382844 @default.
• W2415708755 hasAuthorship W2415708755A5021358102 @default.
• W2415708755 hasAuthorship W2415708755A5026695094 @default.
• W2415708755 hasAuthorship W2415708755A5038304654 @default.
• W2415708755 hasAuthorship W2415708755A5047746565 @default.
• W2415708755 hasAuthorship W2415708755A5082837962 @default.
• W2415708755 hasAuthorship W2415708755A5086939354 @default.
• W2415708755 hasAuthorship W2415708755A5087023094 @default.
• W2415708755 hasConcept C126322002 @default.
• W2415708755 hasConcept C16005928 @default.
• W2415708755 hasConcept C2780425889 @default.
• W2415708755 hasConcept C2780664588 @default.
• W2415708755 hasConcept C501593827 @default.
• W2415708755 hasConcept C71924100 @default.
• W2415708755 hasConcept C86803240 @default.
• W2415708755 hasConcept C89423630 @default.
• W2415708755 hasConcept C90924648 @default.
• W2415708755 hasConceptScore W2415708755C126322002 @default.
• W2415708755 hasConceptScore W2415708755C16005928 @default.
• W2415708755 hasConceptScore W2415708755C2780425889 @default.
• W2415708755 hasConceptScore W2415708755C2780664588 @default.
• W2415708755 hasConceptScore W2415708755C501593827 @default.
• W2415708755 hasConceptScore W2415708755C71924100 @default.
• W2415708755 hasConceptScore W2415708755C86803240 @default.
• W2415708755 hasConceptScore W2415708755C89423630 @default.
• W2415708755 hasConceptScore W2415708755C90924648 @default.
• W2415708755 hasIssue "6" @default.
• W2415708755 hasLocation W24157087551 @default.
• W2415708755 hasLocation W24157087552 @default.
• W2415708755 hasOpenAccess W2415708755 @default.
• W2415708755 hasPrimaryLocation W24157087551 @default.
• W2415708755 hasRelatedWork W1509643833 @default.
• W2415708755 hasRelatedWork W1969952312 @default.
• W2415708755 hasRelatedWork W2006282215 @default.
• W2415708755 hasRelatedWork W2010030927 @default.
• W2415708755 hasRelatedWork W206262219 @default.
• W2415708755 hasRelatedWork W2089218783 @default.
• W2415708755 hasRelatedWork W2166671040 @default.
• W2415708755 hasRelatedWork W2197152547 @default.
• W2415708755 hasRelatedWork W3165474653 @default.
• W2415708755 hasRelatedWork W4230970531 @default.
• W2415708755 hasVolume "4" @default.
• W2415708755 isParatext "false" @default.
• W2415708755 isRetracted "false" @default.
• W2415708755 magId "2415708755" @default.
• W2415708755 workType "article" @default.